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Abstract
Background/Aims: Serotonin (5-HT) is a chief modulator of intestinal activity. The effects of 
5-HT depend on its extracellular availability, which is mainly controlled by serotonin transporter 
(SERT), expressed in enterocytes. On the other hand, innate immunity, mediated by Toll-like 
receptors (TLRs) and nucleotide oligomerization domain (NOD)-like receptors (NLRs), is known 
to control intestinal microbiota and maintain intestinal homeostasis. The dysregulation of the 
intestinal serotonergic system and innate immunity has been observed in inflammatory bowel 
diseases (IBD), the incidence of which has severely increased all over the world. The aim of 
the present study, therefore, was to analyze the effect of NOD2 on intestinal SERT activity and 
expression, as well as to study the crosstalk of NOD2 with TLR2 and TLR4. Methods: Intestinal 
epithelial cell line Caco-2/TC7 was used to analyze SERT activity and SERT, NOD2, TLR2 and 
TLR4 molecular expression by real-time PCR and western blotting. Moreover, intestinal tract 
(ileum and colon) from mice deficient in TLR2, TLR4 or TLR2/4 receptors was used to test the 
interdependence of NOD2 with these TLR receptors. Results: NOD2 activation inhibits SERT 
activity in Caco-2/TC7 cells, mainly due to the decrement of SERT molecular expression, with 
RIP2/RICK being the intracellular pathway involved in this effect. This inhibitory effect on 
SERT would yield an increment of extracellular 5-HT availability. In this sense, 5-HT strongly 
inhibits NOD2 expression. In addition, NOD2 showed greater interdependence with TLR2 than 
with TLR4. Indeed, NOD2 expression significantly increased in both cells treated with TLR2 
agonists and the intestinal tract of Tlr2-/- mice. Conclusions: It may be inferred from our data 
that NOD2 could play a role in intestinal pathophysiology not only through its inherent innate 
immune role but also due to its interaction with other receptors as TLR2 and the modulation 
of the intestinal serotonergic system decreasing SERT activity and expression.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is an essential intestinal neuromodulator, mainly 
synthesized by enterochromaffin cells from the intestinal epithelium, where it is released 
to apical and basolateral cell surfaces, activating specific 5-HT receptors and triggering 
different responses [1]. 5-HT is critical in the control of the whole intestinal physiology 
because it mediates several functions, such as motility, secretion or absorption [2], and has 
also been involved in several intestinal inflammatory processes [3]. 5-HT activity principally 
depends on its extracellular availability, mostly regulated by the serotonin transporter 
(SERT) located in the apical and basolateral membranes of enterocytes. 5-HT is taken up by 
SERT from the interstitial space into enterocytes, ending its effects. Serotonin extracellular 
levels are subsequently controlled by the equilibrium between serotonin synthesis (by 
enterochromaffin cells) and uptake (by SERT from the enterocyte membrane), which is 
vital for the triggering of 5-HT effects. Apart from the essential importance of 5-HT in the 
maintenance of intestinal balance, serotonin also plays a critical role at the systemic level [4].
Several studies have described the important implications of intestinal serotonergic 
alterations in many chronic gastrointestinal diseases, including inflammatory bowel diseases 
(IBD). In this context, recent works have shown that 5-HT [5], 5-HT receptors [6] and SERT 
[7] would play a chief role in the development of IBD. In fact, recent studies have suggested 
that modifications of the activity of selective serotonin receptors and reuptake transporter 
in the gut could be effective for controlling IBD activity and associated symptoms [8, 9].
In addition to the serotonergic system, modifications in intestinal innate immunity have 
also been described in IBD [10]. Pattern recognition receptors (PRRs) are innate immune 
components, which mainly involves Toll-like receptors (TLRs) and nucleotide oligomerization 
domain (NOD)-like receptors (NLRs). PRRs are expressed in intestinal epithelial cells [11, 
12] and are able to recognize microbial-associated molecular patterns (MAMPs) to develop 
either inflammatory or tolerance responses [13]. In this context, several studies have 
reported that numerous PRRs, as TLR2, TLR4 [14] and NOD2 [15], seem to be implicated in 
IBD due to the dysfunctional recognition of commensal microbiota [16]. TLR2 is expressed 
in the cell surface and can detect molecular patterns associated with Gram-positive bacteria 
[17] through their heterodimers (TLR2/1 and TLR2/6) [18] while TLR4, also located on 
the cell surface, detects lipopolysaccharide (LPS), the major cell wall component of Gram-
negative bacteria [19].
Regarding NLRs, NOD2 is a cytoplasmic receptor expressed in intestinal epithelial cells, 
which recognizes a specific peptidoglycan shared by both Gram-positive and Gram-negative 
bacteria: muramyl dipeptide (MDP) [20]. NOD2 plays a key role in intestinal homeostasis, 
developing a tolerance response to the commensal microbiota and protecting the host 
against pathogenic microorganisms through pro-inflammatory intracellular pathways, such 
as NF-κB [11].
Recent works have shown that both TLR2 and TLR4 activation downregulates intestinal 
serotonin transporter activity and expression [21, 22]. However, the implication of other 
PRRs, such as NOD2, in the intestinal serotonergic system remains unknown. Therefore, the 
aim of this work was to analyze the effects of NOD2 activation on SERT activity and molecular 
expression. Moreover, we have also aimed to study the possible interaction between NOD2 
with TLR2 and TLR4.
Materials and Methods
Reagents and antibodies
The following drugs and substances were used (abbreviations and respective suppliers in 
parentheses): serotonin (5-hydroxytryptamine, 5-HT) from Sigma–Aldrich (St. Louis, MO, USA) and 
[3H]-5-HT (specific activity 28 Ci/mmol) was from Perkin-Elmer (Boston, MA, USA). N-glycolytated 
muramyldipeptide-NOD2 ligand (MDP), lipopolysaccharide (LPS; Escherichia coli O111:B4), N114 
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Palmitoyl-S-[2, 3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-
lysine (Pam3CSK4), S-[2, 3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-
[S]-lysyl-[S]-lysine x 3 CF3COOH (Pam2CSK4) and Gefitinib RIP2 Tyrosine Kinase Inhibitor (gentamicin, 
receptor interacting protein-2 [RIP2] inhibitor) from InvivoGen (San Diego, CA, USA) were also used. The 
specific primary antibodies used are indicated in Table 1. The secondary antibodies coupled to horseradish 
peroxidase were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All generic reagents were 
purchased from Sigma-Aldrich and Roche Applied Sciences (Sant Cugat del Vallés, Barcelona, Spain).
Cell culture
This study was carried out with the human enterocyte-like cell line Caco-2/TC7 [23]. We have used 
these human epithelial cells as in vitro model, since previous works have demonstrated that this cell line 
expresses SERT and innate immunity receptors, thus being an optimal intestinal model for analyzing SERT 
[24] and PRRs [12, 25]. Caco2/TC7 cells were cultured at 37°C in an atmosphere of 5% CO2 with high-
glucose DMEM, supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 1% non-
essential amino acids and 20% heat-inactivated fetal bovine serum (FBS) from Life Technologies (Carlsbad, 
CA, USA). The medium was changed two days after seeding and daily afterwards. The experiments were 
carried out nine days after reaching confluence (14 days after seeding), as SERT activity is maximal at this 
point [24]. The cell medium was free of FBS 24 hours before the experiment to avoid interference. NOD2 
agonist (N-glycolytated muramyldipeptide, MDP) and the different modifiers were added to the culture 
medium at different concentrations and periods. Prior to the experiments, the cell monolayer was analyzed, 
and none of the different conditions seemed to affect the morphology, proliferation or monolayer integrity 
of the Caco-2/TC7 cells (data not shown).
Animals
Wild-type C57BL/10ScSn mice (WT) as well as TLR2-deficient C57BL/10ScSn (Tlr2-/-), TLR4-deficient 
C57BL/10ScN (Tlr4-/-) and TLR2/TLR4 double-deficient C57BL/10ScN mice (Tlr2, 4-/-) [26] were bred at 
the Centro de Investigación y Tecnología Agroalimentaria (CITA, Zaragoza, Spain). All of the mice genotypes 
were periodically tested. Mice from 10 to 12 weeks of age were used in the experiments and were maintained 
under pathogen-free conditions on a 12-hour light/dark cycle with food and water ad libitum. The Ethic 
Committee for Animal Experiments of the Zaragoza University (P136/12) approved the experiments 
carried out in this study. The care and use of animals were performed in accordance with the Spanish Policy 
for Animal Protection RD53/2013, which meets the European Convention for the Protection of Vertebrate 
Animals used for Experimental and other Scientific Purposes (Council of Europe Nº 123, Strasbourg 1985) 
and the European Union Directive 2010/63/EU on the protection of animals used for scientific purposes. 
Mice euthanasia was performed by using cervical dislocation, and immediately after that, the intestinal 
tract (ileum and colon) was removed and cleaned with an ice solution of NaCl 0.9%. Intestinal samples for 
RNA studies were collected in RNAlater from Qiagen (Hilden, Germany), stored for one day at 4°C and then 
subsequently frozen at -80°C. The samples for protein analyses were immediately frozen in ice-cold isopropyl 
alcohol and stored at -80°C.
5-HT uptake studies
Uptake measurements 
were performed in cell cultures 
in 24-well plates, as previously 
described [24], either under 
the control condition or after 
treatment with a specific NOD2 
ligand. The transport medium 
composition in mM was as 
follows: 137 NaCl, 4.7 KCl, 1.2 
KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 
10 HEPES pH 7.4, 4 glutamine, 
1 ascorbic acid, 0.1% BSA, and 
both 0.2 μM 5-HT and [3H]-5-HT 
Table 1. Primary antibodies used for western blot analysis. Primary 
antibodies were purchased from (a) Abcam (Cambridge, UK) and (b) 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Capital letters indicate 
animal species: M: mouse; R: rat; Rb: rabbit; H: human; G: goat
 
Antibody reference Description Species reactivity Dilution 
Anti-SERT ab130130 a G polyclonal M, R, Rb, H 1:1,000 
Anti-NOD2 ab197030 a Rb monoclonal M, R, H 1:2,500 
Anti-TLR2 ab24192 a Rb polyclonal M, H 1:1,000 
Anti-TLR4 ab13556 a Rb polyclonal M, H 1:1,000 
Anti-Actin SC-1615 b G polyclonal M, R, H 1:10,000 
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(1.5 μCi/ml) as the substrate. Before uptake studies, cells were pre-incubated at 37°C in an atmosphere of 
5% CO2 with a substrate-free transport medium for 30 minutes. The cells were washed with the substrate 
free transport medium at 37°C and then, incubated with the transport medium at 37°C for 6 minutes.
The uptake was stopped by removing the transport medium and washing the cells twice with an ice-
cold transport medium containing 20 μM 5-HT. Finally, the cells were solubilized in 0.5 ml of 0.1 N NaOH 
and a sample of 200 μl taken for radioactivity counting (Wallac Liquid Scintillation Counter, Perkin-Elmer). 
The protein concentration was calculated using the Bradford method from Bio-Rad (Hercules, CA) with BSA 
as the standard. All results were calculated in pmol 5-HT/mg protein being and expressed as a percentage 
of the control value (100%).
RNA extraction, reverse transcription and real-time PCR
Caco-2/TC7 cells were cultured in 6-well plates and total RNA was extracted using the RNeasy mini 
kit and the RNase-free DNase set from Qiagen, following the manufacturer’s protocol. For intestinal RNA 
extraction, prior the use of the RNeasy mini kit, the samples were thawed in an ice-cold lysis RTL buffer 
(Qiagen) and homogenized using the Ultra Turrax T25 from IKA (Staufen, Germany). The extracted RNA 
(1 μg) was used as a template for first-strand cDNA synthesis using oligo(dT) primers and a reverse 
transcriptase (Lucigen, Middleton, USA). A negative amplification was done without reverse transcriptase. 
The cDNAs obtained by reverse transcription (RT) were used to determine the mRNA level by real-time PCR 
using SYBR Green.
The quantification of the SERT, NOD2, TLR2 and TLR4 mRNA in Caco-2/TC7 cells and NOD2 mRNA 
in mice was carried out by using the StepOne Plus Real-Time PCR System (Applied Biosystems, Foster 
City, USA), with GAPDH and HPRT1 as housekeeping. The specific primers used are detailed in Table 2. 
All samples analyzed were determined in triplicate, and the fluorescence raw data were analyzed by the 
Applied Biosystems StepOne Software v2.3 (Applied Biosystems). Thus, the mRNA relative expression was 
calculated as ΔΔCt = ΔCtcontrol – ΔCttreatment, being ΔCt = Ctgene – Ctcalibrator. Finally, the levels of the relative gene 
expression were transformed and expressed as the fold difference (=2-ΔΔCt).
Cell homogenates and brush border-enriched fraction for western blot analysis
Caco-2/TC7 cells were cultured in 75 cm2 flasks and the cell brush border membrane-enriched 
fraction was obtained following the method described in a previous paper [27]. The cells were washed 
twice with PBS and re-suspended with an ice-cold Tris-mannitol buffer (2 mM Tris, 50 mM Mannitol, pH 
7.1) containing protease inhibitors and 0.02% sodium azide. The samples were disrupted using a Potter-
Elvehjem homogenizer with a PTFE pestle and the obtained suspension was homogenized and disrupted by 
sonication (fifteen 1-s bursts, 60W). The brush border membrane-enriched fraction was obtained through 
the addition of 20 mM CaCl2 to the cell lysate and was maintained for 10 minutes in ice. After this time, samples 
were centrifuged for 10 minutes at 950 g. The supernatant was centrifuged (30 minutes, 40, 000 g) and the 
pellet was re-suspended in a phosphate buffer (10 mM KH2PO4/K2HPO4 pH 6.8) to obtain the brush border 
membrane-enriched fraction. 
Mice intestinal samples (ileum 
and colon) were cleaned and 
homogenized using ultra-turrax 
in Tris-mannitol buffer pH 7.1 
[21]. Then, all of the samples 
were disrupted using a Potter-
Elvehjem homogenizer with a 
PTFE pestle and the obtained 
suspension was homogenized 
and disrupted by sonication 
(fifteen 1-s bursts, 60W). All 
protein samples were measured 
using the Bradford method (Bio-
Rad).
Cell lysate and brush 
border-enriched fraction from 
Table 2. Primer sequences used for real-time PCR analysis of human 
(h) cells or intestinal mice (m) samples 
Name Forward primer (5’-3’) Reverse primer (5’-3’) 
hSERT GGCCTGGAAGGTGTGATCA GCGCTTGGCCCAGATGT 
hNOD2 CTGGCAAAGAACGTCATGCTA CCTGGGATTGAATCTTGGGAA 
hTLR2 GAAAGCTCCCAGCAGGAACATC GAATGAAGTCCCGCTTATGAAGACA 
hTLR4 TTGAGCAGGTCTAGGGTGATTGAAC ATGCGGGACACACACACTTTCAAATA 
hGADPH CATGACCACAGTCCATGCCATCACT TGAGGTCCACCACCCTGTTGCTGTA 
hHPRT1 CTGACCTGCTGGATTACA GCGACCTTGACCATCTTT 
mNOD2 CTTCATTTGGCTCATCCGTAG CTGGAGATGTTGCAGTACAAAG 
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Caco-2/TC7 cells (60 µg of total protein) as well as ileum and colon homogenates (30 µg) of WT, Tlr2-/-, Tlr4-
/- and Tlr2, 4-/- mice were electrophoresed in 8% SDS-PAGE gels and later transferred to PVDF membranes 
by electroblotting. Membranes were blocked with 4% non-fat dried milk plus 1% BSA and were probed with 
the primary antibodies and their correspondent concentration indicated in Table 1. Primary antibodies were 
detected using specific secondary antibodies coupled with horseradish peroxidase and the WesternBright 
Sirius HRP substrate from Advansta (Menlo Park, CA, USA). In addition, the signal was visualized used 
VersaDoc™ from Imaging System Bio-Rad. After stripping, membranes were re-probed with anti β-actin 
antibody (Table 1) for the determination of differences in the sample loading. The SERT, NOD2, TLR2 and 
TLR4/β-actin protein ratio was calculated in densitometry units using Quantity One 1-D Analyses Software 
from Bio-Rad, and the results were expressed as a percentage of the control values (100%).
Statistical analyses
All results were expressed as the mean ± the standard error of the mean (SEM). Statistical comparisons 
were performed using Student’s unpaired t-test or one-way ANOVA. One-way ANOVA was followed by the 
Bonferroni post-test with a confidence interval of 95% (p < 0.05). Previously, normal distribution was 
confirmed with the D’Agostino-Pearson test. The statistical analysis is indicated in each figure and was 
developed with the computer-assisted Prism GraphPad Program (Prism version 5.03, GraphPad Software, 
San Diego, CA).
Results
SERT inhibition by NOD2 activation in Caco-2/TC7 cells
Several studies have already described NOD2 expression in myeloid and lymphoid 
cells, but also in non-hematopoietic cells, such as Paneth cells, stem cells, goblet cells and 
enterocytes [28]. Nevertheless, we considered it essential to detect NOD2 expression in our 
enterocyte-like model. For this reason, we determined NOD2 mRNA and protein expression 
in Caco-2/TC7 cells by RT-PCR and western blot respectively (data not shown). NOD2 mRNA 
was amplified by PCR (317 bp amplicon size) and the NOD2 protein was immunodetected in 
cell homogenates, with both agreeing with the expected NOD2 mRNA and protein size.
After NOD2 expression was demonstrated, we analyzed the effect of NOD2 activation 
by muramyl dipeptide (MDP) on SERT activity in Caco-2/TC7 cells. Thus, cells were treated 
with different MDP concentrations (1, 10 and 50 µg/ml) for a short (30 minutes), medium 
(6 hours) or long (1 day) term, and afterwards, 5-HT uptake was measured. The results 
showed that NOD2 activation with MDP significantly diminished 5-HT uptake with short 
and medium-term treatment. However, with long-term MDP treatment, 5-HT uptake was 
significantly diminished only with the higher MDP concentration (Fig. 1A).
Because NOD2 activation decreases SERT activity, we measured the effect of NOD2 
activation in SERT molecular expression in Caco-2/TC7 cells. Thus, cells were treated for 1 
day with MDP 50 µg/ml and the SERT mRNA and protein levels were analyzed. The results 
showed that activation of NOD2 over a period of 1 day strongly decreased the SERT mRNA 
level (85%) (Fig. 1B), and similarly, SERT protein expression was notably reduced in cells 
treated with MDP in both the cell homogenate (42%) and apical membrane (30%) (Fig. 1C). 
The lowest inhibition observed in SERT protein expression would be due to the SERT protein 
turnover in these cells. Therefore, NOD2 activation inhibits SERT activity in Caco-2/TC7 cells 
and induces a significant decrease of SERT molecular expression.
RIP2/RICK intracellular signaling pathway is involved in NOD2 inhibitory effect on SERT
To gain in depth knowledge about the NOD2 inhibitory effect on SERT activity and 
expression, the intracellular signaling pathway involved was studied. To do so, 1 hour before 
the cell treatment with MDP (50 µg/ml) for 1 day, the cells were pre-treated with a specific 
RIP2 inhibitor (gentamicin 1 µM) and then the 5-HT uptake was measured.
Results showed that the specific RIP2 inhibitor (gentamicin) reversed the NOD2 
inhibitory effect on SERT activity in the Caco-2/TC7 cell line (Fig. 2A). Moreover, gentamicin 
alone did not appear to affect 5-HT transport. To confirm the role of the RIP2/RICK pathway 
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in the long-term effect of NOD2 activation, SERT mRNA and protein expression was 
determined in the same conditions mentioned above – 1 day of treatment with MDP 50 µg/
ml with or without gentamicin. These data suggest that the specific RIP2 inhibitor rescued 
the SERT mRNA reduction that MDP induced (Fig. 2B). SERT protein expression was also 
studied in similar conditions and, in accordance with the previous results, the RIP2 inhibitor 
reversed the SERT protein level reduction that MDP induced in both the cell homogenate and 
apical membrane (Fig. 2C).
5-HT feedback regulation of NOD2 expression
From the results above, we can conclude that NOD2 activation by MDP inhibits SERT 
activity and expression in Caco-2/TC7 cells. As a result, SERT inhibition could lead to an 
increase of 5-HT extracellular availability in the intestinal epithelium, which has been 
Fig. 1. SERT function and expression after NOD2 
activation. A. 5-HT uptake was measured after 6 
minutes of incubation of 5-HT 0.2 μM. MDP con-
centrations assayed were 1, 10 and 50 μg/ml. The 
treatment periods were 30 minutes (short term), 6 
hours (medium term) and 1 day (long term). The 
results are expressed as the percentage of the up-
take control (100%) and are the mean ± SEM of 
seven independent experiments. Absolute control 
values were 7.71±0.61, 5.77±0.7 and 7.0±1.1 pmol 
5-HT/mg protein at 30 minutes, 6 hours and 1 day, 
respectively. B: Real-time PCR analysis of the SERT 
mRNA expression level in cells treated for 1 day 
with MDP 50 μg/ml. Relative quantification was 
performed using comparative Ct method (2–ΔΔCt). 
Results are expressed as arbitrary units (control 
= 1) and are the mean ± SEM of five independent 
experiments. C: Immunodetection of SERT by western blot in cell lysate and apical membrane from Caco-2/
TC7 cells treated with NOD2 50 μg/ml for 1 day. The quantitation of SERT protein using β-actin as an inter-
nal control of the protein load (SERT/β-actin ratio) was achieved. The results are expressed as a percent-
age of the control value and are the mean ± SEM of four independent experiments. *P<0.05, **P<0.01 and 
***P<0.001 compared with the corresponding control value.
Fig. 2. RIP2/RICK intracellular pathway is in-
volved in MDP effect on SERT. Caco-2/TC7 cells 
were treated for 1 day with MDP 50 μg/ml and/
or gentamicin 1 μM. A. Uptake of 5-HT was mea-
sured after 6 minutes of incubation of 5-HT 0.2 μM. 
Absolute control value was 6.03±0.45 pmol 5-HT/
mg protein. The results are expressed as the per-
centage of the uptake control (100%) and are the 
mean ± SEM of four independent experiments. B. 
Real-time PCR analysis of SERT mRNA expression. 
Relative quantification was performed using com-
parative Ct method (2–ΔΔCt). Results are expressed 
as arbitrary units (control = 1) and are the mean 
± SEM of three independent experiments. C. Im-
munodetection and quantification of SERT protein 
expression level by western blot in both cell lysate and apical membrane of Caco-2/TC7 cells. Results are 
expressed as SERT/β-actin ratio and are the mean ± SEM of four independent experiments. **P<0.01 and 
***P<0.001 compared with the corresponding control value.
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demonstrated to be a common factor in IBD [3]. Nonetheless, the effect of 5-HT in NOD2 
molecular expression has not yet been determined. To do so, cells were treated for 1 day 
with low (physiological) or high (pathological) concentrations of 5-HT (10-8 M or 10-4 M 
respectively). The results showed that NOD2 mRNA expression was strongly decreased in 
the treated cells with both 5-HT concentrations, without a difference between them (Fig. 
3A). NOD2 protein expression was also analyzed and a similar decrease in the NOD2 protein 
level was found (Fig. 3B and Fig. 3C).
Interdependence among TLR2, TLR4 and NOD2 in Caco-2/TC7 cells
The above results show that NOD2 activation decreases SERT expression and activity. 
Similarly, previous results have concluded that TLR2 (either TLR2/1 or TLR2/6) and TLR4 
activation decrease significantly 5-HT uptake in Caco-2/TC7 cells [21, 22]. Moreover, the 
over-expression of both receptors has been implicated in IBD [14]. Accordingly, we have 
analyzed the possible interaction between TLR2 and TLR4 with NOD2. For this, Caco-2/TC7 
cells were treated with TLR4 agonist (LPS 30 µg/ml), TLR2/1 agonist (Pam3CSK4 10 µg/
ml) and TLR2/6 agonist (Pam2CSK4 100 ng/ml) for 1 day, after which the NOD2 mRNA 
and protein expression were assessed. The results showed that the NOD2 mRNA level 
was significantly decreased in cells treated with LPS (TLR4 agonist). Moreover, the NOD2 
mRNA level increased after TLR2/6 activation, whereas TLR2/1 activation did not induce 
an alteration in NOD2 mRNA expression (Fig. 4A). In line with the mRNA results, NOD2 
protein expression was significantly increased by TLR2/6 activation and non-changes after 
TLR4 activation; however, TLR4 activation decreased NOD2 protein expression but not 
significantly (Fig. 4B).
Fig. 3. Serotonin inhibits NOD2 expression. Caco-
2/TC7 cells were treated with 5-HT 10-4 and 10-8 
M for 1 day. A. Real-time PCR analysis of NOD2 
mRNA expression level. Relative quantification was 
performed using comparative Ct method (2–ΔΔCt). 
Results are expressed as arbitrary units (control = 
1) and are the mean ± SEM of three independent 
experiments. B. Immunodetection of NOD2 by 
western blot in cell lysate of treated cells. C. Quan-
tification of NOD2 protein relative expression in 
treated cells using β-actin as an internal control of 
the protein load (NOD2/β actin ratio). The results 
are expressed as a percentage of the control value 
(100%) and are the mean ± SEM of three independent experiments. **P<0.01 and ***P<0.001 compared 
with the control value.
Fig. 4. Activation of TLR2 and TLR4 modulates NOD2 expression. Cells were 
treated with LPS 30 μg/ml (TLR4 ligand), Pam3CSK4 10 μg/ml (TLR2/1 li-
gand) or Pam2CSK4 100 ng/ml (TLR2/6 ligand) for 1 day. A. Real-time PCR 
analysis of NOD2 mRNA expression in treated cells. Relative quantification 
was performed using comparative Ct method (2–ΔΔCt). Results are expressed 
as arbitrary units (control = 1) and are the mean ± SEM of four independent 
experiments. B. Immunodetection and quantification of NOD2 protein ex-
pression in cell lysate using β-actin as an internal control of the protein load 
(NOD2/β actin ratio). The results are expressed as a percentage of the con-
trol value (100%) and are the mean ± SEM of six independent experiments. 
**P<0.01 and ***P<0.001 compared with the control value.
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We also analyzed the effect of NOD2 activation on TLR2 and TLR4 expression. Here, 
Caco-2/TC7 cells were treated with NOD2 ligand (MDP 50 µg/ml) for 1 day, and then, TLR2 
and TLR4 mRNA and protein expression was assessed. These data showed that the TLR2 and 
TLR4 mRNA expression level was decreased after NOD2 activation (Fig. 5A); however, TLR2 
and TLR4 protein expression was unchanged (Fig. 5B).
Analysis of NOD2 expression in ileum and colon of  Tlr2-/-, Tlr4-/ -and Tlr2, 4-/- mice
To corroborate the previous results, we analyzed NOD2 expression in the ileum and 
colon of Tlr2-/-, Tlr4-/- and Tlr2, 4-/- mice. In the ileum, NOD2 mRNA (Fig. 6A) and protein (Fig. 
6B) expression strongly increased in Tlr2-/- mice, whereas NOD2 expression did not seem 
to be modified in Tlr4-/- and Tlr2, 4-/- mice (Fig. 6A and Fig. 6B). Regarding the colon, NOD2 
mRNA and protein expression followed a similar pattern to the ileum, being significantly 
increased only in Tlr2-/- mice (Fig. 6C and Fig. 6D). Surprisingly, NOD2 expression seemed not 
to be modified in both ileum and colon from double knockout Tlr2, 4-/- compared with WT 
mice, suggesting a possible collaborative action between TLR2 and TLR4.
Discussion
It is well known that most of the body’s serotonin (5-HT) is synthesized and stored in 
the intestine (approximately 95%). 5-HT is recognized as a signaling molecule implicated 
in a wide number of physiological (gastrointestinal and non-gastrointestinal) functions [2], 
being also implicated in the development and maintenance of gut inflammatory pathologies, 
such as IBD [8]. These pathologies also involve altered intestinal innate immunity [29], 
which plays an important role in intestinal homeostasis.
In this paper, we have described how NOD2 activation decreases intestinal SERT activity 
and molecular expression, through the RIP2/RICK intracellular signaling pathway. The 
Fig. 5. NOD2 modulates TLR2 and TLR4 expression. Cells were treated with 
MDP 50 μg/ml for 1 day. A. Real-time PCR analysis of TLR2 and TLR4 mRNA 
expression in treated cells. Relative quantification was performed using com-
parative Ct method (2–ΔΔCt). Results are expressed as arbitrary units (control = 
1) and are the mean ± SEM of four independent experiments. B. Immunodetec-
tion and quantification of TLR2 and TLR4 protein expression in cell lysate using 
β-actin as an internal control of the protein load (TLR2 and TLR4/β actin ratio). 
The results are expressed as a percentage of the control value (100%) and are 
the mean ± SEM of five independent experiments. ***P<0.001 compared with 
the control value.
Fig. 6. NOD2 expression in ileum (A, B) and colon (C, 
D) of Tlr2-/-, Tlr4-/-, and Tlr2,4-/- mice. Real-time PCR 
analysis of NOD2 mRNA expression level in ileum (A) 
and colon (C) of knockout mice. Relative quantifica-
tion was performed using comparative Ct method 
(2–ΔΔCt). Results are expressed as arbitrary units (WT 
= 1) and are the mean ± SEM of five animals. Immu-
nodetection and quantification of NOD2 by western 
blot in ileum (B) and colon (D) of knockout mice, us-
ing β-actin as an internal control of the protein load 
(NOD2/β-actin ratio). The results are expressed as a 
percentage of the control value (100%) and are the 
mean ± SEM of four animals. *P<0.05, **P<0.01 and 
***P<0.001 compared with the control value.
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inhibitory effect on SERT activity yields an increment of extracellular 5-HT, which seems 
not to affect NOD2 expression. Analysis of SERT activity showed that NOD2 activation, in the 
short and medium terms, reduces SERT activity at all of the concentrations of MDP tested. 
However, NOD2 long-term activation showed that only the highest concentration of MDP 
used was able to reduce SERT activity, with a reduction of SERT molecular expression. This 
suggests that long-term NOD2 activation may decrease SERT expression via transcriptional 
and/or post-transcriptional mechanisms, offering an explanation for the 5-HT uptake 
reduction. In agreement with our results, other PRRs have also demonstrated inhibition of 
SERT activity with [21, 22] or without [30] alteration of SERT expression.
The activation of NOD2, with low concentrations of MPD, induces an inhibitory effect 
observed only in the short (30 minutes) and medium terms (6 hours), suggesting that a brief 
stimulation of NOD2 induces a rapid inhibition of SERT activity, increasing 5-HT extracellular 
availability to promote a fast inflammatory response. The observed effect in the long term 
may be due to the activation of mechanisms that could regulate NOD2 over-activation after 
a long-term treatment [31]. In this case, only a high concentration of MDP in the long term 
would maintain NOD2 activation [32].
The inhibition of SERT expression and activity by NOD2 activation would lead to 
an increase of the 5-HT extracellular availability, which could induce the effect on NOD2 
expression via feedback regulation. Our results have shown that 5-HT strongly diminished 
NOD2 mRNA and protein expression, suggesting that 5-HT could act as a repressor of NOD2 
expression. However, when we compared high 5-HT concentration (10-4 M), which occurs 
in inflammatory pathologies [2] with lower (5-HT, 10-8 M) physiological conditions no 
significant differences were observed in NOD2 expression, suggesting that a NOD2 induced 
extracellular 5-HT increase would not modify the observed effect. Previous studies, however, 
have demonstrated feedback regulation between TLR2 and 5-HT [21], where a high 5-HT 
concentration decreases TLR2 expression, modulating TLR2 responses. Our results 
demonstrate that 5-HT, an intestinal non-immunological modulator, could regulate the 
expression of innate immune receptors in different ways and may contribute to modulation 
of the intestinal response to inflammation.
This study has demonstrated that NOD2 activation could inhibit SERT activity and 
expression through the RIP2/RICK intracellular pathway. Other pro-inflammatory pathways 
have been pointed out as being implicated in SERT activity [33, 34], but the implication of 
RIP2/RICK in SERT activity has not been studied until now, although several studies have 
shown that MDP could act throughout RIP2/RICK to develop pro-inflammatory responses 
[35]. In fact, recent results have demonstrated that MDP could increase the infiltration of 
inflammatory-related cells and intestinal damage with a transcript expression increment 
of NOD2 and RIP2/RICK [36]. Moreover, several works have shown that pro-inflammatory 
factors inhibit SERT [37, 38].In addition, serotonin has been also reported as a pro-
inflammatory molecule in the intestine because SERT knockout mice showed exacerbated 
intestinal inflammation due to an uncontrolled increase of mucosal 5-HT levels [39, 40]. In 
this context, experimental colitis was also more intense in SERT knockout mice compared 
with WT, suggesting the critical implication of serotonin and SERT in intestinal inflammation 
[39, 40]. In this sense, gut microbiota have also been linked to immune responses and to 
the pathophysiology of intestinal inflammatory disease. Several members of the microbiota 
produce metabolites, including serotonin. These metabolites induce intestinal epithelial 
cells to release molecules that modulate cell signaling [41]. Indeed, spore-forming bacteria, 
primarily Clostridium spp., modulated the colonic luminal metabolome, including short-
chain fatty acids, thereby inducing serotonin biosynthesis by enterochromaffin cells [42].
The innate immune system needs both TLRs and NLRs for developing an effective 
response against potential pathogens in the gut. Numerous studies have shown that 
crosstalk takes place between different TLRs, especially between TLR2 and TLR4 in different 
cell types [43, 44]. However, these results seem to be controversial. Some investigations 
showed synergy between PRRs to improve the intestinal defense [45] and to promote the 
inflammatory situation [46], whereas other authors pointed out that TLRs and NLRs are 
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inversely related, with the activation of one PRR inhibiting the other [47]. In this regard, and 
considering that TLR2 and TLR4 also inhibit SERT expression and activity [21, 22], we have 
analyzed the possible relation between TLR2 and TLR4 with NOD2 to clarify the role of NOD2 
in homeostasis and inflammation. Our results showed that only TLR2/6 activation increased 
significantly NOD2 expression (mRNA and protein) in Caco-2/TC7 cells. In addition, NOD2 
activation decreased TLR2 mRNA in Caco-2/TC7 cells. To confirm the interdependence 
between TLR2 and NOD2 in the intestinal tract, NOD2 expression in the ileum and colon of 
Tlr2-/- mice was analyzed. Surprisingly, Tlr2-/- mice also showed increased NOD2 expression 
(mRNA and protein) in both the ileum and colon, although TLR2 activation upregulated 
NOD2 expression. However, recently, we observed that Tlr2-/- mice had increased TLR4 
expression and vice versa [25], suggesting a compensatory mechanism between TLR2 and 
TLR4 expression that might explain our results. Similarly, we have recently demonstrated 
that Tlr2-/- mice also exhibit increased expression of SERT [21].
In agreement with our results, recent studies showed a synergic effect between NOD2 
and TLR2 [48], where specific NOD2 activation with MDP increased the induction of TNFα, 
IL-1 and IL-10 upon co-stimulation with TLR2 agonists. Other studies showed that the 
activation of NOD2 could modify the expression of TLR2 negatively, although this seems 
to be determined by the different kinds of studied cells [49]. However, it seems that NOD2 
could also recognize the specific bacterial fragments recognized by TLR2 heterodimers 
(TLR2/1 and TLR2/6) [50]. Therefore, TLR2 could act synergistically with NOD2 in the 
MAMP’s recognition, and this recognition would increase NOD2 expression, reinforcing the 
inflammatory process. Moreover, increased NOD2 expression in both ileum and colon of 
Tlr2-/- mice may mean that the lack of TLR2 could be compensated by the increment of the 
NOD2 receptor to maintain the intestinal homeostasis.
In contrast to TLR2, it seems that TLR4 activation by LPS treatment in Caco-2/TC7 cells 
decreases the NOD2 mRNA level, without causing changes in protein expression, suggesting 
transcriptional NOD2 modifications that apparently are not translated into NOD2 protein 
modifications. It may be possible that LPS treatment for one day was not enough to trigger 
a decrease in NOD2 protein expression but would be sufficient for decreasing significantly 
NOD2 mRNA expression. These results are not in agreement with recent studies in which 
macrophages treated with LPS increased NOD2 mRNA expression, although it could be due 
to the different cell model used [51]. Moreover, NOD2 activation seemed to decrease TLR4 
mRNA level. In relation to NOD2 expression in the intestinal tract of Tlr4-/- mice, it seems that 
there was no compensation response by NOD2 as a result of missing TLR4 activity. NOD2 
molecular expression (mRNA and protein) was modified neither in the ileum nor in the colon 
of Tlr4-/- and Tlr2, 4-/-  mice. Other factors could also be implicated in NOD2 regulation, where 
the lack of receptors TLR2 and TLR4 leads to a non-modification of the NOD2 level. Thus, as 
the intestinal tract results showed, regulation of NOD2 may be different with the absence of 
TLR2 or/and TLR4 in the ileum and colon, producing a different response to microorganisms. 
In this context, several studies have indicated a possible TLR2-TLR4 interaction, which could 
explain the different results from single and double knockout [52, 53].
In summary, our work shows that NOD2 activation inhibits SERT activity and expression 
in intestinal epithelial cells and proposes RIP2/RICK as the signaling pathway involved. 
Therefore, the intracellular detection of bacteria by NOD2 would induce an increase 
in intestinal 5-HT levels through the inhibition of SERT, contributing in this way to the 
inflammatory response against the pathogenic bacteria but also by interacting with other 
PRR as TLR2 and TLR4 to trigger several defense pathways (Fig. 7). Moreover, elevated 
levels of 5-HT could affect the intestinal physiology, contributing to the symptoms of a 
gastrointestinal disorder as diarrhea, increase motility, and abdominal pain. In this context, 
the activation of others PRRs, such as TLR2 and TLR4, would affect NOD2, and in turn, NOD2 
activation could influence both TLRs, which also seems to modify SERT. Thus, intestinal 
serotonin is widely modulated by innate immunity to maintain intestinal homeostasis and 
inflammation.
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